MedTrace Logo

Short-Term Effects of Trigger Point Dry Needling on Neuromuscular Control in Individuals Following Anterior Cruciate Ligament Reconstruction

NCT07039240 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-06-26

No results posted yet for this study

Summary

This single-blind, randomized controlled trial aims to investigate the effects of dry needling on neuromuscular control in individuals with anterior cruciate ligament reconstruction during a single-leg vertical drop landing task. Participants in the intervention group will receive dry needling, while those in the control group will not receive any therapeutic intervention.

The main research question is:

• Can dry needling induce changes in muscle activation, co-contraction magnitude, and biomechanical parameters during landing?

Conditions

  • Anterior Cruciate Ligament Reconstruction

Interventions

PROCEDURE

Dry needling

The dry needling intervention will follow the fast-in and fast-out technique using disposable stainless-steel needles (0.35 × 40 mm). After insertion with a quick thrust, the needle will be manipulated in multiple directions to elicit at least one local twitch response (LTR). Once the first LTR is obtained, the needle will be moved vertically within a range of 3-5 mm, without rotation, until a total of three LTRs are elicited. The intervention is expected to last approximately 25-30 seconds.

Sponsors & Collaborators

  • Universidad Rey Juan Carlos

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-03
Primary Completion
2025-04-30
Completion
2025-06-11

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07039240 on ClinicalTrials.gov